Intas Rumored As Another Suitor For Biogen’s Biosimilars Business
Reports Of Interest From Accord Parent Company Follow Earlier Samsung Bioepis Rumor
• By David Wallace
Biogen has seen interest from multiple parties in its biosimilars business • Source: Shutterstock 
